155 results on '"Ciaravino, V."'
Search Results
2. PCR36 Content Validity, Acceptability, and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary and the Electronic Hidradenitis Suppurativa Symptom Questionnaire
3. PCR224 Acceptability and Usability of the Electronic Hidradenitis Suppurativa Quality of Life Questionnaire
4. Bimékizumab montre une amélioration maintenue à long terme des critères patients (PRO) et de la qualité de vie dans la spondyloarthrite ankylosante : résultats à 3 ans d’une étude de phase IIb
5. Réponse au bimékizumab jusqu’à 3 ans de traitement chez des patients atteints de psoriasis en plaques modéré à sévère ayant répondu après 16 semaines : résultats de l’extension en ouvert de BE RADIANT
6. Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial
7. PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis
8. MSR64 Psychometric Validation of the Electronic Hidradenitis Suppurativa Quality of Life (eHiSQOL) Questionnaire Using Pooled Data from the Phase 3 BE HEARD Trials of Bimekizumab in Hidradenitis Suppurativa
9. MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS
10. Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials
11. Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)
12. Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial
13. PBI56 Psychometric Validation of the P-SIM, a NOVEL Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis
14. Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)
15. The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging
16. Preclinical safety profile of plasma prepared using the INTERCEPT Blood System
17. The Absence of Reproductive Toxicity Demonstrated by the INTERCEPT Blood System for Platelets
18. Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course
19. Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios
20. DIFFERENZIAZIONE DEL GRADING TUMORALE DEI TUMORI NEUROENDOCRINI DEL PANCREAS (PNET) MEDIANTE 3D CT TEXTURE ANALYSIS E RELATIVE CT ENHANCEMENT RATIOS E LORO COMPARAZIONE
21. PB2260 THE JOURNEY PRO STUDY: FEASIBILITY AND USER ACCEPTANCE OF A SMARTPHONE APP TO ASSESS THE BURDEN OF ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), β-THALASSEMIA (BT), AND MYELOFIBROSIS (MF)
22. 3D-CT texture analysis of neuroendocrine pancreatic neoplasms
23. 3D CT texture analysis of neuroendocrine pancreatic neoplasms
24. CT texture analysis of downstaged ductal adenocarcinoma after chemoteraphy in predicting treatment response
25. Perfusion CT changes in liver metastases from pancreatic neuroendocrine tumours during everolimus treatment
26. IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS.
27. Balloon-Expandable Intraarterial Stents: Effect of Antithrombotic Medication on Thrombus Formation
28. Syndromic surveillance system based on near real-time cattle mortality monitoring
29. Diagnostic insonation of extra utero human placentas: No effect of lymphocytic sister chromatid exchange
30. Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets
31. Diagnostic ultrasound and sister chromatic exchanges: failure to reproduce positive findings
32. Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course: Glasgow, UK. 3–5 October 2016
33. High capacity in vitro micronucleus assay for assessment of chromosome damage: results with quinolone / naphthyridone antibacterials
34. Absence of an Ultrasound Effect on In Vitro Lymphocyte Sister Chromatid Exchange.
35. Iodine Release as an Indicator of Acoustic Cavitation.
36. Lack of Effect of High Intensity Pulsed Ultrasound on Sister Chromatid Exchange.
37. Ouabain and Infarction Effects on Contrast Media Induced Ventricular Fibrillation
38. Factors Modifying Contrast Media Induced Fibrillation
39. FIBRILLATION DOSE DURING CORONARY ARTERIOGRAPHY
40. Lack of ultrasound effect on in vitro human lymphocyte sister chromatid exchange
41. Diagnostic Ultrasound and Sister Chromatid Exchanges
42. Lack of effect of high-intensity pulsed ultrasound on sister chromatid exchange and in vitro chinese hamster ovary cell viability
43. Reply to Todd
44. DSA in acute gastrointestinal hemorrhage: clinical and in vitro studies.
45. Preclinical Safety Assessment of Photochemically-Treated Platelets: No Toxicologically Relevant Effects with Large Multiples of the Clinical Exposure.
46. Simultaneous micronucleus and chromosome aberration assessment in the rat
47. Genotoxicity assessment of pirmenol, a new antiarrhythmic drug
48. The effect of immediate implant placement on alveolar ridge preservation compared to spontaneous healing after tooth extraction: soft tissue findings from a randomized controlled clinical trial
49. Contrast enhancement ultrasound application in focal liver lesions characterization: a retrospective study about guidelines application (SOCEUS–CEUS survey)
50. Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.